IRADIMED CEO linked trust sells 2,500 shares
IRADIMED CORP director and CEO Roger E. Susi reported indirect open‑market sales of 2,500 shares of Common Stock through the Phillip Susi 2008 Dynasty Trust.
Rhea-AI Filing Summary
IRADIMED CORP director and CEO Roger E. Susi reported indirect open‑market sales of 2,500 shares of Common Stock through the Phillip Susi 2008 Dynasty Trust. The shares were sold on June 1, 2026 in multiple trades at weighted average prices between $88.68 and $91.91, under a pre‑arranged Rule 10b5‑1 trading plan adopted on November 5, 2025.
After these sales, the Phillip Susi 2008 Dynasty Trust held 2,162,500 shares. Separate indirect holdings reported include 2,062,500 shares held by the Matthew Susi 2008 Dynasty Trust and 162,950 shares held by the Roger E. Susi Revocable Trust. Susi disclaims beneficial ownership beyond his pecuniary interest in these trust‑held shares.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 2,500 shares
Net Sell
6 txns
Insider
Susi Roger E.
Role
CEO, President, Chairman
Sold
2,500 shs ($227K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 400 | $88.68 | $35K |
| Sale | Common Stock | 775 | $89.79 | $70K |
| Sale | Common Stock | 401 | $91.08 | $37K |
| Sale | Common Stock | 924 | $91.91 | $85K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 2,162,500 shares (Indirect, By Phillip Susi 2008 Dynasty Trust);
Common Stock — 162,950 shares (Indirect, By Roger E. Susi Revocable Trust);
Common Stock — 2,062,500 shares (Indirect, By Matthew Susi 2008 Dynasty Trust)
Footnotes (6)
- F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025.
- F2. This transaction was executed in multiple trades at prices ranging from $88.10 to $88.87. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3. This transaction was executed in multiple trades at prices ranging from $89.29 to $90.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. This transaction was executed in multiple trades at prices ranging from $90.69 to $91.58. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. This transaction was executed in multiple trades at prices ranging from $91.75 to $92.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose.
Key Figures
Shares sold: 2,500 shares
Sale price (weighted average example): $91.91/share
Post-sale holdings – Phillip Susi 2008 Dynasty Trust: 2,164,600 shares
+3 more
6 metrics
Shares sold
2,500 shares
Total Common Stock sold indirectly on June 1, 2026
Sale price (weighted average example)
$91.91/share
One reported weighted average sale price for June 1, 2026 trade
Post-sale holdings – Phillip Susi 2008 Dynasty Trust
2,164,600 shares
Indirect Common Stock holdings after June 1, 2026 sales
Holdings – Matthew Susi 2008 Dynasty Trust
2,062,500 shares
Indirect Common Stock holdings reported as of June 1, 2026
Holdings – Roger E. Susi Revocable Trust
162,950 shares
Indirect Common Stock holdings reported as of June 1, 2026
Net share change
-2,500 shares
Net sell direction across reported non-derivative transactions
Key Terms
Rule 10b5-1 trading plan, weighted average sale price, pecuniary interest, Section 16, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average sale price financial
"The price reported above reflects the weighted average sale price."
pecuniary interest financial
"The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein"
Section 16 regulatory
"shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose."
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
indirect ownership financial
"direct_or_indirect: "I", nature_of_ownership: "By Phillip Susi 2008 Dynasty Trust""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did IRMD insider Roger E. Susi report in this Form 4?
Roger E. Susi reported indirect sales of IRADIMED CORP stock. A trust associated with him sold 2,500 shares of Common Stock on June 1, 2026 under a Rule 10b5-1 plan, while significant indirect trust holdings remain reported.
Were the IRMD insider stock sales made under a Rule 10b5-1 plan?
Yes, the reported sales were made under a Rule 10b5-1 plan. The filing states they were effected pursuant to a pre-arranged trading plan adopted by the reporting person on November 5, 2025, indicating the transactions were scheduled in advance.
What other indirect IRMD holdings are reported for Roger E. Susi?
Two additional trusts report indirect IRADIMED holdings. The Matthew Susi 2008 Dynasty Trust holds 2,062,500 shares and the Roger E. Susi Revocable Trust holds 162,950 shares of Common Stock, as reported in the same Form 4 filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.
